Fresh Tracks Therapeutics, Inc.
FRTXDelisted Dec 27, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000819050
Fresh Tracks Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Jun 11, 2024; 15 institutions reported holding it in 13F filings for Q3 2023, worth $455.8K in total; no superinvestor held it.
Holders of 5% or more of FRTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Fresh Tracks Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Fresh Tracks Therapeutics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Fresh Tracks Therapeutics, Inc., newest first.
No Schedule 13D or 13G filings on Fresh Tracks Therapeutics, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Fresh Tracks Therapeutics, Inc. shares.
No Form 144 notices for Fresh Tracks Therapeutics, Inc. are on file.